Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21 R110.

Paul J Hengeveld, Y Emre Ertem, Julie M N Dubois, Clemens H M Mellink, Anne-Marie van der Kevie-Kersemaekers, Ludo M Evers, Kim Heezen, P Martijn Kolijn, Olaf R F Mook, M Mahdi Motazacker, Kazem Nasserinejad, S Kersting, Peter E Westerweel, Carsten U Niemann, Arnon P Kater, Anton W Langerak, Mark-David Levin*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

9 Downloads (Pure)
Original languageEnglish
Pages (from-to)1935-1938
Number of pages4
JournalLeukemia
Volume36
Issue number7
DOIs
Publication statusE-pub ahead of print - 18 May 2022

Cite this